Back

Usefulness of 2-year iodine-123 metaiodobenzylguanidine-based risk model for the post-discharge risk stratification in patients with acute decompensated heart failure

31 August 2019 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Poster Session 1 - Rare cases of heart failure Epidemiology, Prognosis, Outcome ESC Premium Access ESC Congress 2019

About the speaker

Photo
Doctor Shunsuke Tamaki

Ehime University Graduate School of Medicine, Toon (Japan)

9 More presentations in this session

Presentation thumbnail
Iron status indices (transferrin saturation, serum ferritin) in the course of acute myocarditis: relations with neurohormonal activation, cardiac dysfunction and clinical recovery
Mr P. Franczuk (Wroclaw, PL)
Abstract
Presentation thumbnail
The impact of levothyroxine on cardiac function in older adults with subclinical hypothyroidism: a randomized clinical trial
Professor B. Gencer (Lausanne, CH)
Abstract Slides
Presentation thumbnail
The hemodynamic and prognostic effects of thyroid dysfunction types in heart failure: two sides of the blade
Associate Professor M. Cetin (Ankara, TR)
Presentation thumbnail
Methamphetamine-associated cardiomyopathy: a case-controlled study of clinical characteristics, management and outcomes
Doctor T. Wang (Cleveland, US)
Abstract Slides
Presentation thumbnail
Zika myocarditis prior diabetes bring out the worst
Doctor K. Gonzalez Carta (Rochester, US)

Access the full session

Session thumbnail
Poster Session 1 - Rare cases of heart failure

The Event

Event poster

ESC Congress 2019

31 August - 4 September 2019

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources